Submission of Matters to a Vote of Security Holders – Form 8-K
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
(Exact Name of Registrant as Specified in Charter)
1-11848 | 43-1627032 | |||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
( Identification No.) |
(Address of Principal Executive Offices, and
Registrant's telephone number, including area code: (636)736-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading |
|
||
Common Stock, par value |
RGA | |||
5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056 | RZB | |||
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 | RZC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter):
☐ Emerging growth company
☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 |
Submission of Matters to a Vote of Security Holders. |
At the Annual Meeting, the Company's shareholders were asked to vote on the election of eleven directors and the three other proposals described below, and the votes were cast as follows:
1. |
Election of the following directors for terms expiring in 2024 or until their respective successors are elected and qualified: |
For | Against | Abstain | Broker Non-Votes |
|||||||||||||
|
57,067,418 | 1,136,430 | 39,022 | 2,307,883 | ||||||||||||
|
57,465,122 | 753,358 | 24,390 | 2,307,883 | ||||||||||||
|
57,970,109 | 246,834 | 25,927 | 2,307,883 | ||||||||||||
|
57,958,504 | 259,033 | 25,333 | 2,307,883 | ||||||||||||
|
58,124,374 | 94,710 | 23,786 | 2,307,883 | ||||||||||||
|
56,827,974 | 1,389,469 | 25,427 | 2,307,883 | ||||||||||||
George Nichols III |
57,072,404 | 1,122,098 | 48,368 | 2,307,883 | ||||||||||||
|
57,876,119 | 340,991 | 25,760 | 2,307,883 | ||||||||||||
Shundrawn Thomas |
56,794,059 | 1,417,410 | 31,401 | 2,307,883 | ||||||||||||
|
57,999,874 | 217,100 | 25,896 | 2,307,883 | ||||||||||||
|
57,966,825 | 250,111 | 25,934 | 2,307,883 |
2. |
Advisory vote on the frequency of the shareholders' vote to approve the compensation of the Company's named executive officers: |
1 Year |
2 Years |
3 Years |
Abstain |
Broker Non-Votes |
||||
56,726,574 | 137,339 | 1,331,475 | 47,482 | 2,307,883 |
The Company's Board of Directors has decided, consistent with its recommendation and the vote of shareholders, to hold the advisory vote on executive compensation on an annual basis until the 2029 Annual Meeting of Shareholders, which will be the next required vote on the frequency of the shareholder vote on the compensation of named executive officers, although an earlier vote may be held at the discretion of the Board of Directors.
3. |
Advisory vote to approve the compensation of the Company's named executive officers: |
For |
Against |
Withheld |
Broker |
|||
55,278,726 | 2,904,259 | 59,885 | 2,307,883 |
4. |
Proposal to ratify the appointment of |
For |
Against |
Withheld |
Broker |
|||
58,460,659 | 2,060,064 | 30,030 | 0 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: |
By: |
/s/ |
|||
Senior Executive Vice President and Chief Financial Officer |
Attachments
Disclaimer
I helped expose insurers for denying medical claims. 15 years on, a court has found what they did is illegal
Lawmakers have a lot of ideas on Medicaid. Here are the highlights.
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News